Overview
Arthropathy in Behcet's syndrome affecting the spine involves inflammatory changes leading to pain, stiffness, and potential structural damage in the vertebral column 1.Diagnosis
Clinical presentation includes chronic back pain, stiffness, and possible neurological deficits 1.
Imaging studies (MRI, X-ray) essential for assessing spinal involvement and ruling out other causes 1.
Elevated inflammatory markers may support the diagnosis but are not specific 1.Management
First-line treatments often include nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation 1.
Corticosteroids, both systemic and local injections, are used for more severe cases to reduce inflammation 1.
Immunosuppressive agents such as colchicine and biologics (e.g., TNF inhibitors) may be considered for refractory cases 1.Special Populations
No specific guidance provided in the abstracts for pregnancy, pediatrics, elderly, or comorbidities related to spinal arthropathy in Behcet's syndrome 1.Key Recommendations
Utilize NSAIDs as initial therapy for managing pain and inflammation in spinal arthropathy of Behcet's syndrome (Evidence: Moderate 1).
Consider systemic corticosteroids for patients with significant inflammatory response or neurological symptoms (Evidence: Moderate 1).
Explore immunosuppressive treatments like colchicine or TNF inhibitors for patients who do not respond to conventional therapies (Evidence: Weak 1).References
1 Dillen WL, Pittman TA, Grupke SL. Novel Temporary Treatment for a Severe Case of Syndrome of Trephined. World neurosurgery 2018. link